© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Science News

hepatitis B, HBV
Bulevirtide Is a Safe and Effective Treatment for Hepatitis D
Blogs: The community speaks
Forums: Support and discussion

Study Links Synthetic Chemicals to Liver Damage

PFAS, synthetic chemicals found in many common products, may be contributing to an increase in liver problems, such as fatty liver disease.

Still Few Answers as Kids Hepatitis Outbreak Spreads

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

Hepatitis C Treatment Is Effective for People 65 and Older

However, older people were more likely to experience adverse events, especially if they used ribavirin.

Fatty Liver Disease Increased During COVID-19 Pandemic

Higher daily alcohol consumption was linked to greater risk for MAFLD.

Mysterious Hepatitis Outbreak Hitting Kids in U.K. and U.S.

The current leading suspect is an adenovirus, but much more remains to be learned.

New COVID Vaccine May Better Protect Cancer Patients

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

MUST read

Celebrities With Hepatitis
10 Tips to Protect Your Liver
Hep Stories: Get inspired
The 2017 Hepatitis C Treatment Pipeline
EASL 2017 Roundup: Continued Progress in Fighting Liver Disease
11 Signs of Liver Disease

NIH Begins Clinical Trial Evaluating Second COVID-19 Booster Shots in Adults

NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.

Universal Hepatitis C Screening During Pregnancy Detects More Cases

Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.

ER Visits, Hospital Stays Drop for People Successfully Treated for Hepatitis C

Antiviral therapy reduced the need for hospitalization and emergency treatment for liver-related and other conditions.

FDA Approves Second COVID Booster for People 50 and Older

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Women With Irregular Menstrual Cycles May Have Increased NAFLD Risk

The higher risk for women with longer periods does not appear to be related to obesity.

Hot topics

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics
NASH: The Basics
Antibodies attacking SARS-CoV-2, the coronavirus that causes COVID-19

COVID-19 Immune Response Improves for Months After Vaccination

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

Need HIV/HCV Therapy Plus Drug Use Treatment? Try a Federal Facility

Pickings for concurrent treatment are slim in Ending the HIV Epidemic rural communities.

COVID Vaccine Boosters Protect People With Immune Dysfunction

Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.

Social Media Intervention Improves Hepatitis B Knowledge Among Korean Americans

Screening for hepatitis B virus and liver cancer prevention were promoted through the KakaoTalk app.

Hepatitis C Screening During Emergency Visit Improves Linkage to Care for Baby Boomers

Men and Black people were more likely to have antibodies against hepatitis C virus.
Advertisement
Newsfeed
Features

Hot topics

Forums: Support and discussion
Blogs: The community speaks
Hep Stories: Get inspired
Magazine: Search the archives
#Coffee
A smiling Caucasian couple
#BabyBoomers

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.